PLATELET-ACTIVATING-FACTOR (PAF)-INDUCED CHEMOTAXIS AND PAF BINDING TO HUMAN EOSINOPHILS

被引:0
|
作者
FUKUDA, T [1 ]
NUMAO, T [1 ]
AKUTSU, I [1 ]
MAKINO, S [1 ]
机构
[1] DOKKYO UNIV,SCH MED,DEPT MED & CLIN IMMUNOL,MIBU,TOCHIGI 32102,JAPAN
来源
JOURNAL OF LIPID MEDIATORS | 1992年 / 5卷 / 02期
关键词
PAF; EOSINOPHILS; CHEMOTAXIS; PAF BINDING;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Compared to PAF-induced platelet aggregation, the chemotactic response to PAF of human eosinophils requires higher PAF concentrations, suggesting a lower binding affinity of PAF for the eosinophil. To test this possibility, we examined the binding of PAF by human eosinophils. The dose range of unlabeled PAF required to produce inhibition of [H-3]PAF binding was roughly the same as that for induction of chemotaxis, and was much higher than that in platelets as reported in the literature. These results indicate that the affinity of PAF for the eosinophil is considerably less than that for the platelet, and may explain the higher EC50 for eosinophil chemotaxis.
引用
收藏
页码:145 / 149
页数:5
相关论文
共 50 条
  • [1] SPECIFIC BINDING OF PLATELET-ACTIVATING-FACTOR (PAF) BY HUMAN EOSINOPHILS
    FUKUDA, T
    NUMAO, T
    MAKINO, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1987, 79 (01) : 172 - 172
  • [2] PLATELET-ACTIVATING-FACTOR (PAF) AND PAF ANTAGONISTS IN ASTHMA
    HOSFORD, D
    MENCIAHUERTA, JM
    BRAQUET, P
    CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 1990, 7 (03): : 261 - 273
  • [3] IMAGE ANALYSES OF PLATELET-ACTIVATING-FACTOR (PAF)-INDUCED CA TRANSIENTS IN HUMAN SINGLE EOSINOPHILS
    NARA, M
    KAKUTA, Y
    AIZAWA, T
    OSHIRO, T
    TAMURA, G
    SHIRATO, K
    TAKISHIMA, T
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04): : A822 - A822
  • [4] INHIBITION OF PLATELET-ACTIVATING FACTOR (PAF)-INDUCED CHEMOTAXIS AND PAF BINDING TO HUMAN EOSINOPHILS AND NEUTROPHILS BY THE SPECIFIC GINKGOLIDE-DERIVED PAF ANTAGONIST, BN-52021
    KURIHARA, K
    WARDLAW, AJ
    MOQBEL, R
    KAY, AB
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 83 (01) : 83 - 90
  • [5] PLATELET-ACTIVATING-FACTOR (PAF) AND LYSO-PAF IN INFLAMED HUMAN SKIN
    BARR, RM
    JUDGE, M
    MALLET, AI
    KOBZABLACK, A
    BARLOW, R
    GREAVES, MW
    AGENTS AND ACTIONS, 1994, 41 : C260 - C261
  • [6] PLATELET-ACTIVATING-FACTOR (PAF) - AN INTRODUCTION
    NOJIMA, S
    LIPIDS, 1991, 26 (12) : 965 - 966
  • [7] IMPAIRED LEUKOCYTE CHEMOTAXIS AND PLATELET-ACTIVATING-FACTOR (PAF) PRODUCTION IN PERIDONTITIS
    JENG, KCG
    LING, W
    HSAIO, SH
    CHEN, CY
    KO, YM
    FASEB JOURNAL, 1991, 5 (04): : A636 - A636
  • [8] PLATELET-ACTIVATING-FACTOR (PAF) AND LYSO-PAF IN PSORIASIS
    JUDGE, MR
    BARR, RM
    MALLET, AI
    COURTNEY, F
    BLACK, AK
    GREAVES, MW
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1994, 286 (07) : 376 - 379
  • [9] HUMAN POLYMORPHONUCLEAR LEUKOCYTE ACTIVATION INDUCED BY PLATELET-ACTIVATING-FACTOR (PAF)
    DELMASCHIO, A
    ALBORS, M
    BUCCHI, F
    TOMASIAK, M
    BERTELE, V
    CERLETTI, C
    DEGAETANO, G
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 185 - 185
  • [10] ANTIBODIES TO PLATELET-ACTIVATING-FACTOR (PAF) INHIBIT PAF-INDUCED PLATELET-AGGREGATION
    SMAL, MA
    COONEY, SJ
    BALDO, BA
    JOURNAL OF LIPID MEDIATORS, 1991, 4 (03): : 333 - 341